Older patients had more fused cells in three cancers’ metastases
An observational analysis examined cancer deposits from people with prostate, breast and lung cancers, finding an enrichment of these cells in elderly patients.
Limit: Tissue syncytia were measured; patient survival and clinical outcomes were not measured
Edited by Boris Djordjevic · AgingResearch.News
In metastatic tissue from patients with prostate, breast and lung cancers, an observational analysis found more tumor-like syncytia—fused cells containing many nuclei—in elderly patients. The researchers also conducted experiments outside the body with bone marrow-derived macrophages, a type of immune cell. Aged macrophages showed a greater tendency to form syncytia containing cancer-associated nuclei with a marker of cell division.
These syncytia consumed less oxygen and had lower levels of proteins involved in energy production by mitochondria, the cells’ energy-producing structures. Blocking STAT6, a cell-signaling protein, increased syncytia formation and suppressed mitochondrial energy-production programs. The compound C52 partly restored mitochondrial gene activity and reduced syncytia formation.
Why it matters
The work addresses whether age-related changes in immune-cell energy production may contribute to the formation of unusual tumor-associated cells.
Caveats
The observational tissue analysis could not establish that aging caused syncytia to form in patients. This preprint has not been peer-reviewed, and its abstract does not identify the species used for the macrophage experiments.
The paper
The University of Texas at San Antonio Health Science Center
bioRxiv, May 21, 2026, Open access, CC BY, Preprint, not peer-reviewed
Comments
Be the first to comment.